PVP-Jod AL

Quick links

Choose a section

Quick links to important sections

Advertisements

PVP-Jod AL

Advertisements
Advertisements

Overview of PVP-Jod AL

Property Description
Active ingredient Povidone Iodine (PVP-I)
Pharmacological class Antiseptic / Iodophor
Origin Synthetic Polymer Complex
Common form Solution, Ointment, Surgical Scrub
Route of administration Topical (External)

PVP-Jod AL is an external-use medicine, manufactured by ALIUD Pharma GmbH and often associated with the German market, where it is typically available as a non-prescription (OTC) product. Its active core, Povidone Iodine, functions as a reliable antiseptic for disinfecting the skin surface. Its fundamental role is to manage microbial contamination, focusing exclusively on topical administration.


What Type of Medicine is PVP-Jod AL? (Classification and Origin)

PVP-Jod AL is classified as a topical anti-infective agent belonging to the iodophor group of medicines. Its active ingredient, Povidone Iodine (PVP-I), is broadly recognized for its essential role in infection control, featuring on the World Health Organization's List of Essential Medicines. This international inclusion reflects the substance’s recognized efficacy against pathogens.

The core of the preparation is Povidone Iodine, which is a synthetic chemical complex where germicidal elemental iodine is safely bound to the polymer carrier, Polyvinylpyrrolidone (PVP). This complex represents a significant differentiator, as its chemical structure is designed to be gentler on the tissue compared to older, simple iodine preparations, making it a preferred choice for broader family use.


Composition and Available Topical Forms (Substance and Delivery)

The composition of PVP-Jod AL is defined by the Povidone Iodine complex as the single active constituent, integrated into various bases suitable for the skin and mucous membranes. The preparation is made available for topical administration as an aqueous solution, a hydrophilic ointment, and a specialized surgical scrub formulation. This variety allows users to tailor the application form to the nature of the wound, such as using the ointment for minor sustained coverage or the solution for initial cleansing. The PVP polymer functions as a depot, providing a sustained release system that gradually liberates the free iodine over time directly onto the application site.


What is the General Purpose of Povidone Iodine? (High-Level Benefit)

The overarching purpose of Povidone Iodine preparations is to provide broad-spectrum germicidal action against a wide array of microbial pathogens present on the skin surface. This effect, recognized for its speed and reliability, is rooted in the powerful oxidizing property of elemental iodine, which destroys the cellular components of microbes, including bacteria, viruses, and fungi. By achieving this comprehensive microbe elimination, the preparation supports the general therapeutic goal of cleansing the skin and preventing the establishment of infection following minor trauma, such as a graze or a small cut sustained during yard work.

Regulatory References

  1. World Health Organization's List of Essential Medicines
Advertisements

What side effects are possible with PVP-Jod AL?

Possible side effects and safety information

The safety profile for Povidone Iodine, the active ingredient in PVP-Jod AL, is structured around localized skin reactions and the potential for systemic effects due to iodine absorption, as documented in official regulatory labeling.


Adverse Reaction Classifications

Adverse reactions are formally categorized based on regulatory frequency standards. Localized skin reactions, such as local irritation, skin burns, and sensitivity reactions, are often classified as Rare or Uncommon. Hypersensitivity reactions, including anaphylactic reactions (e.g., hives or swelling), have been reported, sometimes classified as Very Rare or of Not Known frequency due to limited data.

System-Organ Class Key Adverse Reactions (Regulatory Documented)
Skin and Subcutaneous Tissue Disorders Local irritation, contact dermatitis, reversible brown coloration of the skin.
Immune System Disorders Hypersensitivity, Anaphylactic reactions.
Endocrine Disorders Goitre, hypothyroidism, hyperthyroidism (associated with absorption).

Systemic Absorption and Safety Constraints

The most significant safety concern is the risk of systemic iodine absorption, which can lead to Endocrine Disorders like goitre or abnormal thyroid function. This risk is explicitly associated with extensive or prolonged use of the preparation, or application to large areas of broken skin.

Serious adverse reactions officially documented include severe allergic responses, such as anaphylactic shock, and severe systemic toxicity like acute renal failure or metabolic acidosis, which are generally linked to high levels of absorption.

Population-Specific Safety: Use is often restricted in specific populations. The medicine is generally not recommended for regular use during pregnancy or lactation or in neonates and pre-term infants. Caution is also specified for patients with pre-existing thyroid disorders or those receiving concurrent lithium therapy, due to the potential for iodine interference. Additionally, Povidone Iodine may interfere with thyroid function tests.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Povidone Iodine, the active substance in PVP-Jod AL, is defined by the potential for both severe local injury and dangerous systemic toxicity following excessive exposure, typically through ingestion or extensive application on large open wounds.

Domain Official Regulatory Statement
Documented overdose presentations Systemic toxicity may present with severe gastrointestinal symptoms (abdominal pain, vomiting, diarrhea), hypotension (low blood pressure), and tachycardia (fast heart rate).
Physiological systems affected Systemic absorption can lead to profound physiological changes, including metabolic acidosis, hypernatremia, and serious acute renal failure (kidney injury) [NIH MedlinePlus].
Population-specific overdose notes Official labeling identifies neonates, infants, and individuals with pre-existing thyroid dysfunction or kidney impairment as being particularly susceptible to severe systemic effects.
Emergency-response statements Management is strictly symptomatic and supportive, and official sources state that no specific antidote is known [NCBI StatPearls].
When immediate medical help is required Authorities mandate that individuals must seek immediate medical attention or contact a poison control center right away for any suspected overdose or ingestion of the product [NIH MedlinePlus].

The regulatory documentation emphasizes that due to the potential for life-threatening outcomes, such as acute renal failure and circulatory collapse, immediate emergency intervention is required when excessive exposure is suspected. Treatment focuses on supporting vital functions, including correcting severe electrolyte imbalances, as the primary management strategy.

Advertisements

Therapeutic Uses of PVP-Jod AL

What PVP-Jod AL Treats: Main Uses and Benefits

PVP-Jod AL is commonly used in first aid and general wound care to address acute skin barrier disruptions, such as minor cuts, grazes, superficial thermal injuries, and abrasions. In this capacity, its purpose is relevant for easing symptoms related to physical discomfort by providing broad-spectrum germicidal action relevant for the site of trauma. The preparation also plays a role in managing infection prevention within professional settings, often applied in scenarios for rigorous pre-operative skin preparation.

“It is applied across domains where additional symptomatic support is needed, consistent with contexts involving localized discomfort.”

This critical antiseptic function provides support that may assist with easing the overall symptom burden by lowering the risk of local infection, and supports general well-being during symptomatic phases related to common everyday injuries. The preparation is considered relevant for managing conditions presenting with systemic or localized discomfort associated with superficial skin issues.


Quick Fact: Relief for Symptoms that Interfere with Daily Functioning The preparation provides support that helps manage the symptom cluster associated with surface contamination and the potential for increased discomfort.

Regulatory References

  1. US National Library of Medicine (DailyMed) labeling information
Advertisements

Eligibility and Restrictions for Use

The eligibility to use PVP-Jod AL is strictly defined by regulatory authorities due to the risks associated with systemic iodine absorption, particularly in sensitive populations.

Contraindicated Populations (Must Not Use)

The medicine is absolutely contraindicated for patients with:

  • Known hypersensitivity to Povidone-Iodine or its excipients.
  • Manifest hyperthyroidism or other acute thyroid diseases.
  • Dermatitis herpetiformis Duhring.
  • Individuals undergoing or having recently completed radioactive iodine therapy.
  • Infants under 6 months of age (some labels extend this prohibition up to 2 years).

Restricted or Conditional Use

Use is limited or requires medical supervision for:

  • Pregnancy and Lactation: Use must be avoided unless strictly necessary and should be kept to the absolute minimum dosage and area, as iodine may affect the fetal or newborn thyroid.
  • Pre-existing Conditions: Patients with a history of thyroid disorders (like goiter or nodules) or impaired renal function must use the preparation with special caution and often require medical monitoring.
  • Concurrent Medication: Regular application is contraindicated in patients receiving lithium therapy.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for PVP-Jod AL (Povidone Iodine, PVP-I) is defined primarily by local chemical incompatibilities and pharmacodynamic antagonism, consistent with its external, topical application. Systemic pharmacokinetic interactions, such as those mediated by CYP enzymes, are not documented for normal topical use in official regulatory labeling.

Contraindicated and Restricted Combinations

Co-administration with mercuric derivatives is strictly contraindicated because the combination is officially documented to form potentially caustic compounds. Concomitant use with enzymatic wound treatment preparations and certain topical antiseptics is restricted due to mutual inactivation, resulting in a loss of efficacy for both substances. Similarly, co-use with Hydrogen Peroxide, silver compounds, or Taurolidine should be avoided as these substances may cause antagonism or chemical reactions.

Procedural and Population-Specific Constraints

Official regulatory documents mandate specific timing and separation rules for subsequent wound care. The application site must be allowed to dry completely or be thoroughly rinsed and dried before applying products like fibrin sealants or liposomal anesthetics, which are sensitive to PVP-Iodine residue. A specific, officially documented caution exists for newborns, small infants, and patients with existing thyroid dysfunction, where iodine absorption from extensive or prolonged use carries a heightened risk of interfering with metabolic and thyroid function.

Advertisements

Mechanism of Action

The Mechanism of Action of PVP-Jod AL


The Non-Selective Chemical Elimination of Pathogens

This antiseptic operates by a non-selective chemical mechanism, relying on the oxidizing properties of elemental iodine ( I2) released from its carrier. The iodine rapidly targets and destroys vital microbial proteins, lipids, and nucleotides across a broad spectrum of bacteria, viruses, and fungi through processes like halogenation and denaturation. The resulting physiological consequence is the local inactivation of pathogens on the epidermal surface.


Sustained Germicidal Activity via Iodophor Depot System

Polyvinylpyrrolidone (PVP) acts as a controlled-release depot system for the active iodine. This mechanism ensures the germicidal agent is liberated slowly and consistently, governing the onset kinetics to provide an immediate effect while simultaneously maintaining germicidal activity over time. This functionality extends the duration of active iodine release at the application site following the initial rapid cellular destruction.


Mechanistic Limitation: Quenching by Organic Matter

The effectiveness of this chemical mechanism is constrained by the presence of organic matter (e.g., blood, pus, or serum), which readily reacts with and consumes the active free iodine. This quenching reaction limits the amount of iodine available to target microbial components, leading to a decrease in the chemical rate of pathogen inactivation when organic contamination is high.

Advertisements

Dosage and Administration Information

How to Use PVP-Jod AL

The usage of PVP-Jod AL, a preparation based on Povidone Iodine, is established to ensure appropriate application for its designated purposes. The administration method is topical, meaning the product is for external use only and should not be used internally.


Application Procedure and Frequency

For general first-aid purposes, the procedure requires that the affected area be cleaned prior to application of the product. Users should apply a small amount of the formulation (solution or ointment) directly to the site. The standard dosing frequency for minor wounds is typically 1 to 3 times daily. After application, the preparation must be allowed to dry completely before being covered with a sterile bandage, if required.


Official Usage Constraints and Duration

Specific parameters exist regarding both patient population and duration of use. PVP-Jod AL is not to be used in children under 1 year of age and is subject to special restrictions concerning neonates. The duration of use is limited for general first-aid; the solution should not be used for more than 7 days and the ointment for a maximum of 14 days, unless directed by a healthcare professional. Furthermore, the product labeling restricts application from covering large areas of the body and cautions professional users to avoid the pooling of solution beneath patients during prolonged procedures. The application should be discontinued if the condition persists for more than 72 hours.

Advertisements

Recent Clinical Evidence

PVP-Jod AL: Recent Clinical Evidence

Povidone-iodine (PVP-I) is an antiseptic compound widely used across various medical fields, from skin disinfection before surgery to wound care. The clinical evidence primarily focuses on its established broad-spectrum microbicidal activity against bacteria, viruses, fungi, and protozoa. This action is attributed to the gradual release of free iodine, which oxidizes key components within microbial cells.

Recent research has focused on PVP-I's application in several specialized areas:


1. Wound and Surgical Site Infection (SSI) Prevention

Clinical trials have long supported the use of PVP-I for preoperative skin antisepsis and in the management of minor wounds. The evidence suggests that PVP-I and other common antiseptics are appropriate for reducing the risk of SSI, although studies comparing different agents often show mixed or inconsistent findings regarding superiority. PVP-I is noted in some research for its ability to penetrate microbial biofilms, which are complex structures that protect pathogens.


2. Emerging Research Areas

  • Upper Respiratory Hygiene: Following in-vitro evidence, studies have investigated the potential of dilute PVP-I solutions (such as gargles or nasal sprays) to reduce the viral load on the oropharyngeal and nasopharyngeal mucosa in patients with respiratory infections. Clinical trial results in this area are still being analyzed to determine the impact on symptom severity or transmission.
  • Chronic Wound Care: While effective in acute settings, research concerning PVP-I's role in chronic wound management is less conclusive, with some findings suggesting a need for further investigation into optimal concentration and formulation to avoid potential localized tissue effects.

Overall, the compound remains a valuable tool in infection control due to its lack of documented microbial resistance and its broad efficacy spectrum, which continues to be the subject of ongoing clinical evaluation.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about PVP-Jod AL (FAQ)

Q: What is the main difference between PVP-Jod AL and standard iodine?

PVP-Jod AL contains Povidone-Iodine (PVP-I), which is a complex where the active iodine is bound to a polymer carrier. The complex is intended to provide a more controlled release of iodine, which is associated with less localized irritation and potential toxicity compared to older, simple iodine preparations. This information is based on official pharmacological descriptions.


Q: Is it normal for PVP-Jod AL to sting when applied?

Localized skin reactions are listed in official product information as potential side effects. These reactions may include mild skin irritation, which can sometimes manifest as a stinging or burning sensation. Official documentation states that if irritation develops or worsens, the product is indicated to be discontinued.


Q: Can PVP-Jod AL be used on sensitive skin?

Povidone-iodine products carry warnings regarding use in patients with pre-existing skin conditions. Regulatory warnings indicate that use by patients with sensitivities or existing skin issues may require the oversight of a healthcare professional. This guidance is in place because the product may sometimes exacerbate certain skin conditions.


Q: What kind of infections is PVP-Jod AL used for?

PVP-Jod AL is an antiseptic product indicated for the management or prevention of microbial contamination. This includes use for the antisepsis of intact or broken skin and mucous membranes. It is officially labeled for preventing infection in minor cuts, scrapes, and wounds, as well as for preoperative skin preparation.


Q: Is PVP-Jod AL safe for use on the faces of children?

Official warnings on povidone-iodine products restrict use to small areas of the body to limit the possibility of systemic iodine absorption. Given these concerns, the product label indicates that the use of this medicine in children may require consultation with a healthcare team.


Q: What happens if a small amount of PVP-Jod AL is swallowed accidentally?

PVP-Jod AL is strictly for external use and is not intended for ingestion. If any amount is accidentally swallowed, the mouth should be rinsed immediately. Official procedural guidance mandates that users must contact a poison control center or seek emergency medical assistance immediately.


Q: What should I do if the area treated with PVP-Jod AL turns very red?

If a user develops new or worsening symptoms, such as excessive redness, swelling, or increased pain at the application site, official guidance states that the product is indicated to be discontinued. Such severe or persistent reactions could indicate a worsening condition and may require evaluation by a healthcare provider.


Q: Can people who are allergic to shellfish use PVP-Jod AL?

Studies and regulatory information state that shellfish allergies are caused by muscle proteins and are not a risk factor for a true iodine allergy. However, the product is officially contraindicated for anyone with a known hypersensitivity or allergy to povidone-iodine or its excipients.


Q: Can PVP-Jod AL be used on burns?

PVP-Jod AL is indicated for minor first aid uses, including minor cuts, scrapes, and burns. However, use of the medicine on serious burns, deep wounds, or puncture wounds is restricted and requires a physician's oversight.


Q: What is the difference in safety profile between topical iodine and povidone-iodine?

The povidone-iodine complex is noted in regulatory sources for its improved tolerability and nonstaining properties. It is described as having a reduced potential for toxicity and irritancy compared to older, elemental iodine solutions. This difference is largely due to the controlled, slow release of the active iodine from the polymer carrier.


Q: Is there a concentration limit for safe use of PVP-Jod AL?

Regulatory documents restrict use of Povidone-Iodine products to small areas for short durations, typically mathbf7 days or less. While the product may be available in various concentrations, medical practice notes that for ongoing wound care, it is sometimes used after being diluted to concentrations of mathbf1% or lower.


Q: Are there different strengths of PVP-Jod AL, and what do the percentages mean?

Povidone-iodine is produced in various standard concentrations, commonly mathbf7.5%-10.0% in liquid or scrub forms. The percentages typically refer to the concentration of the mathbfpovidone-iodine complex itself. This complex, in turn, contains approximately mathbf9.0%-12.0% of the germicidal component known as available iodine.


Q: Why do people use PVP-Jod AL instead of hydrogen peroxide?

Official information explicitly states that PVP-Jod AL is not indicated for simultaneous use with hydrogen peroxide. The active components in both products cause mutual inactivation, which leads to a loss of the necessary antiseptic effectiveness for both substances on the skin.


Q: How long after application does PVP-Jod AL keep working?

The antiseptic action typically begins rapidly, often within mathbf30 seconds of contact. The slow release of iodine from the PVP carrier is what is designed to provide a sustained or longer lasting antiseptic effect at the application site compared to older iodine preparations.


Q: Can PVP-Jod AL interact with any common skin care products?

The active iodine component readily reacts with proteins and other chemical components. This reaction can interfere with the function of certain enzymatic treatments and other topical agents. Regulatory documents include a general caution that use requires informing the healthcare team about all concomitant medicinal or non-prescription topical products being used.


Q: What research is available on the long-term use of PVP-Jod AL?

Regulatory warnings specifically caution against prolonged use and application over large areas of the body. This restriction is due to the potential risk of systemic iodine absorption and interference with thyroid function. The official duration of use is generally restricted to mathbf7 days for minor first aid applications.


Q: How does povidone-iodine (PVP-Jod) work compared to other antiseptics?

PVP-I acts by a non-selective mechanism of releasing iodine to rapidly destroy microbial cell components. Studies comparing PVP-I to other common antiseptics, such as chlorhexidine, indicate that povidone-iodine has a wider antimicrobial spectrum but may sometimes have a shorter protective effect against bacterial growth on the skin.


Q: Is it okay to use PVP-Jod AL on open wounds?

The product is indicated for the wound antisepsis of small, superficial wounds and for use on intact or broken skin. Official documentation restricts the use of the product on deep wounds or puncture wounds. Use on small superficial wounds is within the labeled indication.


Q: Does PVP-Jod AL have an expiration date, and how is it affected by light?

The product must be stored correctly to maintain its stability, which includes protecting it from light. While the general shelf life varies by formulation, the specific expiration date and the date by which the product must be discarded after opening should always be checked directly on the product label.


Q: What are the general expectations for wound healing when using PVP-Jod AL?

The application of this antiseptic supports the natural process of wound healing by preventing local microbial growth. If the condition persists for more than 72 hours (for minor wounds) or symptoms get worse, the product is indicated to be discontinued and the condition may require evaluation by a healthcare provider.


Q: Is it necessary to remove all previous residue before reapplying PVP-Jod AL?

Regulatory documentation does not explicitly mandate rinsing for the simple reapplication of PVP-Jod AL itself. However, it does require the application site to be thoroughly rinsed and dried before applying subsequent medical products, such as fibrin sealants or specialized wound dressings.


Q: Is PVP-Jod AL meant to treat an already existing infection or prevent one?

Official regulatory documents indicate that PVP-Jod AL is used both to treat minor skin infection and to prevent its establishment. The core function is to kill or prevent the growth of a wide range of microbes on the skin surface.


Q: Can PVP-Jod AL be used on broken skin or mucous membranes?

The product is indicated for antisepsis of both intact skin and broken skin, as well as on mucous membranes. Official warnings state that use on broken skin must be restricted to small areas due to the safety concern regarding systemic iodine absorption.

Advertisements

How should PVP-Jod AL be stored and disposed of?

Storage and Disposal Requirements for PVP-Jod AL

The storage of Povidone-Iodine products must adhere strictly to official regulatory conditions to maintain stability.

Mandatory Storage Conditions

Condition Type Requirement
Temperature Range Store at controlled room temperature (15 C to 30 C) and avoid excessive heat.
Environmental Protection The medicine must be protected from light and moisture.
Freezing/Refrigeration Do not freeze liquid solutions.
Container Integrity The product must be stored in its original container and kept tightly closed when not in use.

Stability and Safety Rules

Certain liquid formulations must be discarded a maximum of 6 months after opening or preparation. As with all medications, PVP-Jod AL must be stored out of the sight and reach of children.

Official Disposal

Unused or expired medicine and its packaging must be disposed of in accordance with local, state, and federal regulatory requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of PVP-Jod AL found in:

A-Z Index: